67 items found

Tags: AE CI Cancer

Filter Results
  • dataset

    SMQ codes related with hepatic disorder and renal disorder.

    SMQ codes related with hepatic disorder and renal disorder.
  • dataset

    Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk...

    BackgroundLenalidomide could effectively induce red blood cell (RBC) transfusion independence (TI) in patients with lower-risk (Low/Intermediate-1) myelodysplastic syndrome...
  • dataset

    r37980778c78--6fbf4ec480f8cb0866b2825f5c8851ac

    Characteristics of included studies.
  • dataset

    Characteristics of the Trials Included in this Study.

    Characteristics of the Trials Included in this Study.
  • dataset

    r37980778c78--ea87fd756143198776d7f66b4977b0f9

    BackgroundPediatric Phase I cancer trials are critical for establishing the safety and dosing of anti-cancer treatments in children. Their implementation, however, must contend...
  • dataset

    r37980778c78--72f035a5ff4546edc9ce0a1a0fda18a5

    Multivariable Conditional Logistic Regression for occurrence of a severe AE (Grade ≥3) (n = 1442) and for occurrence of a severe AE (Grade ≥3) after start of Cycle 2 (n = 1366).
  • dataset

    Unadjusted Prognostic effect and adjusted prognostic effect of PSA on overall...

    Unadjusted Prognostic effect and adjusted prognostic effect of PSA on overall survival.
  • dataset

    Trial characteristics: <i>A</i>. <i>Paniculata</i> versus Placebo (n = 4).

    Trial characteristics: A. Paniculata versus Placebo (n = 4).
  • dataset

    Baseline characteristics of participants.

    Data are presented as mean±SD, median (interquartile range) or percent. Chi-square test for categorical variables, the unpaired t test or Mann-Whitney U test for continuous...
  • dataset

    Comparison of demographics and history of comorbidity between ACOS and non-AC...

    Comparison of demographics and history of comorbidity between ACOS and non-ACOS cohorts.
  • dataset

    Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic ...

    Finding safe and effective treatments for chronic hepatitis C virus (HCV) infection in the elderly is of clinical interest given the comorbidities and associated polypharmacy in...
  • dataset

    Clinical and Demographic Characteristics of Patients.

    Baseline characteristics of patients. All values are expressed as medians and IQRs unless otherwise specified. Continuous variables were compared with Mann-Whitney U test....
  • dataset

    r37980778c78--feef0bb0f285c67c668df7b8171817d1

    Network meta-analyses: PFS, OS, grade 3–5 AE in all-histology NSCLC.
  • dataset

    Characteristics of study subjects.

    JA-1, first-generation Japanese-Americans; JA-2, second- or later-generation Japanese-Americans; BMI, body mass index; BP, blood pressure; 2-h, two-hour post-load; HOMA-IR,...
  • dataset

    r37980778c78--18a5e8f08b55f50a8b1d5d066083ed59

    Analysis Outcomes of Adverse Events (Onabotulinumtoxina versus Placebo).
  • dataset

    Hormone changes from baseline in PLWH.

    Hormone changes from baseline in PLWH.
  • dataset

    Trial characteristics: <i>A</i>. <i>Paniculata</i> (pillule) versus <i>A</i>....

    Trial characteristics: A. Paniculata (pillule) versus A. Paniculata (tablet) (n = 3).
  • dataset

    Summary of adverse events for patients with severe renal impairment<sup>a</sup>.

    Summary of adverse events for patients with severe renal impairmenta.
  • dataset

    r37980778c78--6042153680df7d78736b088242c2ea45

    Meta-analysis and meta-regression of effective sizes in adverse events.
  • dataset

    Sensitivity analysis of overall modelled costs with 10%, 3% or no discount fa...

    Sensitivity analysis of overall modelled costs with 10%, 3% or no discount factor on costs per year.